Reduction of Immunosuppression as Initial Therapy for Posttransplantation Lymphoproliferative Disorder★Ran Reshef, Daniel Tsai, Saran Vardhanabhuti et al.|American Journal of Transplantation|2011Cited by 218
The Impact of EBV Status on Characteristics and Outcomes of Posttransplantation Lymphoproliferative DisorderMarlise R. Luskin, Ran Reshef, Robert H. Vonderheide et al.|American Journal of Transplantation|2015Cited by 174
HLA-haploidentical vs matched unrelated donor transplants with posttransplant cyclophosphamide-based prophylaxisMahasweta Gooptu, Mary Eapen, Rizwan Romee et al.|Blood|2021Cited by 163
Effect of donor characteristics on haploidentical transplantation with posttransplantation cyclophosphamideShannon R. McCurdy, Mary Eapen, Mei-Jie Zhang et al.|Blood Advances|2018Cited by 96
High Graft CD8 Cell Dose Predicts Improved Survival and Enables Better Donor Selection in Allogeneic Stem-Cell Transplantation With Reduced-Intensity ConditioningRan Reshef, David Porter, Austin P. Huffman et al.|Journal of Clinical Oncology|2015Cited by 60